"Prescribing Exercise to Cancer Patients At High-Risk for Falls"

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 3, 2020

Primary Completion Date

August 26, 2024

Study Completion Date

August 26, 2024

Conditions
Cancer
Interventions
OTHER

Pedometer

Participants will wear a pedometer for 4 days at baseline, and 4-6 weeks later. Baseline readings will be used to derive an individualized exercise program for each participant based on the assigned experimental arm.

OTHER

Actigraph

Participants will wear a Actigraph for 4 days at baseline and 4-6 weeks later. Baseline readings will be used to derive an individualized exercise program for each participant based on the assigned experimental arm.

OTHER

Perturbation Treadmill

Participants will walk on an instrumented treadmill while wearing a safety harness at baseline and 4-6 weeks later. The perturbation treadmill will assess an individual's risk for falling. Baseline readings will be used to derive an individualized exercise program for each participant based on the assigned experimental arm.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Andersen Foundation

OTHER

lead

Mayo Clinic

OTHER

NCT04236154 - "Prescribing Exercise to Cancer Patients At High-Risk for Falls" | Biotech Hunter | Biotech Hunter